Some medical AI tools are FDA-regulated, but authorization is not a promise of equal accuracy in every clinic. Here’s what patients should ask.
A knee arthritis study points to real symptom relief with semaglutide, but Medicare access still depends on why it is prescribed and who qualifies.
New CDC data show seasonal allergies affect about 1 in 4 U.S. adults and 1 in 5 children. Here’s how to spot them, treat symptoms, and know when to get care.
As of April 2026, the federal nursing home staffing rule is no longer being phased in. Here’s what it would have required and what families should watch now.
ACA Marketplace coverage in 2026 may require more paperwork, closer plan shopping, and higher premiums for some after extra tax-credit savings ended on Dec. 31, 2025.
Chewing problems can change what older adults eat. Learn how dentures, dry mouth, and sore teeth affect nutrition and when to get care.
New U.S. polling shows many people already ask AI about symptoms and test results. Here’s where it can help, where it can mislead, and when to get human care.
Current U.S. pain guidance says arthritis care should usually start with non-opioid options, with treatment tailored to arthritis type and daily function.
A needle-free epinephrine nasal spray is now available for some patients at risk of anaphylaxis, but fast treatment, backup doses, and emergency follow-up still matter.
New federal ACA Marketplace rules for 2026 tighten some enrollment steps, though some provisions are on hold. Here’s what shoppers should do now.
Federal telehealth prescribing flexibility for ADHD stimulants continues through December 31, 2026. Here’s what changed, what did not, and where barriers remain.
CDC says the United States has reported 1,671 confirmed measles cases in 2026. Here’s what families should check before spring and summer travel.
CDC’s global measles notice means international travelers should check immunity early, not days before departure, and families may need a pre-trip vaccine visit.
Postpartum mental-health support is stretching across the full first year after birth, with longer Medicaid coverage, more screening chances, and a federal hotline.
Two February 2026 cholesterol headlines show how to judge study design, real outcomes, and official guidance before changing a medicine or screening plan.
FDA’s 2026 GLP-1 crackdown targets compounded or illegally marketed products, not approved brands. Here’s how patients can verify what they’re taking.
Whooping cough stayed elevated in the U.S. in 2025. Here’s what that means for family vaccines, test timing, and why clinics want suspected cases to call first.
A Raw Farm cheddar recall offers a practical lesson for families: match the product, size, and date, then return or discard it without tasting it.
SAMHSA’s 2026 988 funding may show up first as faster answers, more local routing, and stronger follow-up, not instant growth in in-person crisis care.
Medicare’s 2026 physician payment rule may improve care coordination, telehealth, and home visits, but local staffing and practice finances still matter.
Some plans now have to post 2025 prior-authorization data. Here is what patients and clinicians can learn from the new CMS reports, and what they cannot.
Minnesota’s Medicaid funding deferral does not automatically end coverage. The closer short-term risk is provider payment strain, tighter oversight, and access friction.
End of content
End of content
